Manchester Capital Management’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-300
Closed -$9.74K 1332
2025
Q2
$9.74K Buy
+300
New +$9.69K ﹤0.01% 824
2023
Q4
Sell
-76
Closed -$2.46K 1059
2023
Q3
$2.46K Hold
76
﹤0.01% 744
2023
Q2
$2.47K Sell
76
-34
-31% -$1.02K ﹤0.01% 714
2023
Q1
$3.5K Sell
110
-8
-7% -$240 ﹤0.01% 686
2022
Q4
$3.55K Sell
118
-13
-10% -$404 ﹤0.01% 588
2022
Q3
$4K Buy
131
+38
+41% +$1.22K ﹤0.01% 548
2022
Q2
$3K Sell
93
-61
-40% -$1.74K ﹤0.01% 641
2022
Q1
$4K Sell
154
-39
-20% -$979 ﹤0.01% 692
2021
Q4
$5K Hold
193
﹤0.01% 673
2021
Q3
$5K Buy
+193
New +$4.48K ﹤0.01% 690
2017
Q2
Sell
-560
Closed -$4K 490
2017
Q1
$4K Buy
+560
New +$3.7K ﹤0.01% 473
2015
Q2
Sell
-224
Closed -$3K 566
2015
Q1
$3K Buy
+224
New +$4.89K ﹤0.01% 528
2014
Q3
Sell
-224
Closed -$7K 1102
2014
Q2
$7K Buy
+224
New +$6.73K ﹤0.01% 989
2013
Q4
Sell
-3,384
Closed -$119K 951
2013
Q3
$119K Buy
+3,384
New +$186K 0.02% 436

Other funds holding OPCH

Manchester Capital Management's OPCH Position: Q3 2025 in Review

Manchester Capital Management sold out of Option Care Health (OPCH) in Q3 2025, closing a stake of 300 shares — an estimated $9.74K sold.

Manchester Capital Management first reported a position in OPCH in Q3 2013 and held it in 14 quarters. The position peaked at $119K in Q3 2013. 381 funds tracked by Wall St. Rank hold OPCH as of Q3 2025.

  • Manchester Capital Management reported no remaining Option Care Health position as of Q3 2025 after selling out during the quarter.
  • Manchester Capital Management sold 300 Option Care Health shares in Q3 2025, an estimated $9.74K.
  • Manchester Capital Management first reported a position in Option Care Health in Q3 2013 and held it in 14 quarters.
  • Manchester Capital Management's Option Care Health position peaked at $119K in Q3 2013.
  • 381 funds tracked by Wall St. Rank held Option Care Health as of Q3 2025.

Based on Manchester Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.